EpiPen pricing debacle and its impact on patients, insurers
A recent spike in the price of EpiPen, a treatment for severe allergic reactions, has caused controversy across the United States, with many now unable to afford the life-saving treatment. Three Northeastern faculty members weighed in on the change, including D'Amore-McKim School of Business professor Gary Young.